Reta GLP-3 (Retatrutide) – 40mg

Description

Retatrutide 40mg is an ultra-high-yield triple-agonist peptide, providing an advanced research tool for intensive metabolic and endocrine studies. This 40mg lyophilized vial is specifically engineered for large-scale research protocols investigating the simultaneous activation of the GLP-1, GIP, and Glucagon (GCG) receptors.

As the most potent concentration in the triple-agonist category, Retatrutide is a primary subject in studies focused on maximized energy expenditure, glycemic control, and the systemic modulation of metabolic pathways.